Naloxone Hydrochloride Injection, Solution
Product Images NDC 36000-310

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 36000-310). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-03 (Carton 03)

NALOXONE HYDROCHLORIDE Injection, USP 0.4 mg/mL (4 mg/10 mL) multiple-dose vial label by Baxter Healthcare Corporation. The label indicates the product is for intravenous, intramuscular, or subcutaneous use, with storage instructions and preservative content details. The vial size is 10 mL.*

FDA Label Image

Container-02 (Container 02)

Label for Naloxone Hydrochloride Injection, USP, 0.4 mg/mL (4 mg/10 mL) multiple-dose vial by Baxter Healthcare Corporation. The label indicates the product is for intravenous, intramuscular, or subcutaneous use, with storage instructions and manufacturing details. The vial contains 10 mL solution, and the label includes usage, lot, and expiration date fields.*

FDA Label Image

Structure-01 (Structure 01)

Chemical structure of naloxone hydrochloride showing the molecular framework including rings, hydroxyl groups, and a hydrochloride hydrate component (HCl . 2H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.